UPDATE 1-Clovis shares dive as FDA asks for more data on lung cancer drug

Nov 16 (Reuters) - Clovis Oncology Inc said the U.S. Food and Drug Administration had asked for additional data on the effectiveness of its lung cancer drug, which could delay an approval for the...